Security key
03168L105
Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX)
CUSIP: 03168L105
Q1 2026 13F Holders as of 31 Mar 2026
- Security type / class
- Equity / Class A Common Stock, par value $0.01
- Total 13F shares
- 159,884,372
- Total 13F value
- $1,987,154,581
- Share change
- +3,856,149
- Put/Call ratio
- 227%
- SEC-reported price per share
- $12.43
- Number of holders
- 315
- Value change
- +$46,873,345
- Number of buys
- 187
- Number of sells
- 115
- Shares outstanding
- 348,532,261
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2026
Institutions
315
Top holders
10
AMRX full security history
Ownership snapshot
Full 13F holder table
Amneal Pharmaceuticals, Inc. SEC filings
Amneal Pharmaceuticals, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of AMRX - Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Akram Mahesh
Disclosed value leader
Dipan Patel
Comparable rows
15/15
Latest evidence
31 Dec 2025
13D/G
3/4/5
13F
Lead comparable stake: 6.6%
13D/G row: Akram Mahesh
Showing 1-6 of 15 holder rows.
Quick read
Akram Mahesh leads the comparable SEC ownership view at 6.6%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Akram Mahesh's linked filing trail.
Comparable ownership
Top 5
Akram Mahesh
6.6%
Dipan Patel
5.4%
VANGUARD GROUP INC
5%
BlackRock, Inc.
4.1%
Rubric Capital Management LP
3.5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Akram Mahesh |
13D/G
|
6.6%
|
$153,779,517
20,558,759 shares
|
$0 | 31 Mar 2025 |
| Dipan Patel |
13D/G
3/4/5
Patel Dipan · Member of 13D Group
|
5.4%
|
$244,942,771
16,904,263 shares
|
-$100,339,323 | 31 Dec 2025 |
| VANGUARD GROUP INC |
13F
13D/G
Company · The Vanguard Group
|
5%
from 13D/G
|
$225,638,469
17,907,815 shares
|
— | 31 Dec 2025 |
| BlackRock, Inc. |
13F
Company
|
4.1%
|
$180,161,353
14,298,520 shares
|
— | 31 Dec 2025 |
| Rubric Capital Management LP |
13F
Company
|
3.5%
|
$155,420,257
12,334,941 shares
|
— | 31 Dec 2025 |
| TPG GP A, LLC |
13F
3/4/5
Company · Former 10% Owner
|
3.5%
|
$155,342,464
12,328,767 shares
|
— | 31 Dec 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
315
Shares
159,884,372
Rows available
315
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2026 vs Q1 2026 Across Filers
Q1 2026 holders
315
Q1 2026 holders
315
Holder diff
0
| Investor | Q1 2026 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q1 2026 value | Value change | Value Chg % |
|---|